Rapid Micro Biosystems to Participate at the Cowen 42nd Annual Health Care Conference
23 févr. 2022 16h45 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2021 Financial Results on March 4, 2022
17 févr. 2022 16h10 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission...
IVD Contract Manufacturing Services (Assay Development, Manufacturing) Markets - Global Forecast to 2028
14 févr. 2022 04h08 HE
|
Research and Markets
Dublin, Feb. 14, 2022 (GLOBE NEWSWIRE) -- The "IVD Contract Manufacturing Services Market by Type (Assay Development, Manufacturing), Category (Reagents, Systems), Technology (Immunoassay, Molecular...
IVD Market Brief Update Report 2021: What is the Size of the Market and the Major Trends Affecting it?
08 févr. 2022 04h58 HE
|
Research and Markets
Dublin, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The "IVD Market Brief Update" report has been added to ResearchAndMarkets.com's offering. What is the Size of the IVD Market in 2021? What Major Trends are...
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
20 janv. 2022 16h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
In Vitro Diagnostic Market Brief Update 2021 - Featuring Agilent, bioMerieux and Hologic Among Others
20 janv. 2022 06h58 HE
|
Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic Market Brief Update" report has been added to ResearchAndMarkets.com's offering. Diagnostic test products have never been more...
Provectus Biopharmaceuticals Announces Publication of Pharmaceutical-Grade Rose Bengal’s Activity Against Gram-Positive Bacteria
10 janv. 2022 06h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical research on a formulation of the Company’s pharmaceutical-grade rose bengal against...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook
09 janv. 2022 18h00 HE
|
Rapid Micro Biosystems, Inc.
Full year 2021 commercial revenue expected to be between $21.3 million and $21.7 million Full year 2022 commercial revenue outlook between $27 million and $32 million Company to Present at the 40th...
BioMe Inc. and Yonsei Medical Center Sign Technology Transfer Contract for Pathbreaking Microbiome Treatment
29 déc. 2021 11h00 HE
|
BioMe
SEOUL, South Korea, Dec. 29, 2021 (GLOBE NEWSWIRE) -- The microbiome treatment market is receiving global attention and is rapidly emerging as a new treatment alternative for various intractable...
Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors
23 déc. 2021 17h16 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...